about
Military service, deployments, and exposures in relation to amyotrophic lateral sclerosis etiology and survivalClinical and experimental applications of sodium phenylbutyrateRecent advances in amyotrophic lateral sclerosisAmyotrophic Lateral Sclerosis: New Perpectives and UpdateAmyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic TrialsMutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosisCystatin C: a candidate biomarker for amyotrophic lateral sclerosisPlasma neurofilament heavy chain levels correlate to markers of late stage disease progression and treatment response in SOD1(G93A) mice that model ALSBeing PRO-ACTive: What can a Clinical Trial Database Reveal About ALS?Platelet serotonin level predicts survival in amyotrophic lateral sclerosisComprehensive rehabilitative care across the spectrum of amyotrophic lateral sclerosis.Deep learning predictions of survival based on MRI in amyotrophic lateral sclerosis.Rehabilitation in amyotrophic lateral sclerosis: why it mattersAmyotrophic Lateral Sclerosis Survival Score (ALS-SS): A simple scoring system for early prediction of patient survival.Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature.Discriminant ability of the Eating Assessment Tool-10 to detect aspiration in individuals with amyotrophic lateral sclerosis.Factors predicting one-year mortality in amyotrophic lateral sclerosis patients--data from a population-based registryComparison of diagnoses of amyotrophic lateral sclerosis by use of death certificates and hospital discharge data in the Danish population.Diagnosis pathway for patients with amyotrophic lateral sclerosis: retrospective analysis of the US Medicare longitudinal claims database.Survival prediction in Amyotrophic lateral sclerosis based on MRI measures and clinical characteristicsProposed association between the hexanucleotide repeat of C9orf72 and opposability index of the thumb.Predicting a positive response to intravenous immunoglobulin in isolated lower motor neuron syndromes.Patients who survive 5 years or more with ALS in Olmsted County, 1925-2004Comparison between Flail Arm Syndrome and Upper Limb Onset Amyotrophic Lateral Sclerosis: Clinical Features and Electromyographic FindingsThe cortical signature of amyotrophic lateral sclerosis.Survival analysis of irish amyotrophic lateral sclerosis patients diagnosed from 1995-2010.The epidemiology of ALS: a conspiracy of genes, environment and time.Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial.Prognostic factors for the course of functional status of patients with ALS: a systematic review.Utilisation of search filters in systematic reviews of prognosis questions.Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patientsIs the effect of non-invasive ventilation on survival in amyotrophic lateral sclerosis age-dependent?TDP-43 pathology in the basal forebrain and hypothalamus of patients with amyotrophic lateral sclerosis.Progression in primary lateral sclerosis: a prospective analysis.Lockhart Clarke's contribution to the description of amyotrophic lateral sclerosis.Pattern of spread and prognosis in lower limb-onset ALS.A fruitful endeavor: modeling ALS in the fruit flyGranulocyte colony-stimulating factor for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled study of Iranian patientsPlasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study.On the development of markers for pathological TDP-43 in amyotrophic lateral sclerosis with and without dementia.
P2860
Q23915088-DB7732A4-E30E-40A7-A336-DB17FCE4C194Q24613511-7A8C0CC4-01DE-4F99-B4F7-427A13C2A4D4Q26749521-CFC42525-1690-4D67-ACEF-3A94F0845669Q26781051-25729D65-4D7E-4028-A49E-4CF161834089Q27021917-D1C82CD9-94C3-4380-8BEB-50C2E0C3D595Q28237200-F93530E0-02E5-4073-86D0-4590C2FE64A1Q28476466-0061A73C-591F-4A0D-8695-381081F155BBQ28481340-05624688-3B4A-4903-A085-80029039F3DFQ28649394-3DAFE3C3-8663-4460-8FB9-A3C8567B5636Q28748875-633E245A-7B17-482A-B532-33CC27771648Q30365902-EA95BECB-1109-4D23-AFB3-9E5485BC1C17Q30365956-B21F2C2E-0B7D-4C9D-B7C2-91FC3429E117Q30407969-523699AE-810E-4805-A205-83B077940278Q30488423-E819274E-DC97-4575-8F78-36B85A83140FQ30580165-2CD3CE9A-A9EC-4795-8604-43C0D0280F40Q30691863-61038B16-DD06-4C93-BE3E-F89BE2E7AB2BQ30857248-0A667EA7-B8B1-4C85-81DB-90A87A82DBA7Q30945338-6BEE792B-9934-4907-9A27-619CBA58BB01Q31150316-A4E12134-5161-4881-A175-9DC0F157830FQ33568729-BA901A79-0861-4E49-9F28-AEB5589F1E78Q33659165-485F8796-F9F1-4301-BE3D-55E008ABCA38Q34069679-FBC1B7E4-4081-4A80-87BB-6CAA2E49EC4CQ34158772-8FF975B9-B107-4A8C-B537-4F0847AE6E17Q34241591-808E0669-65C4-4ED2-B013-A58F4D4FFD9FQ34374772-F19E01D1-959A-4D98-A139-5021254B775BQ34375695-38957FD6-036B-4747-BA11-045D79418ED9Q34377698-04CF6AF8-5FB2-4E88-9001-7D9E7463EECDQ34436090-0607E8EF-77B0-4BBD-9506-32D486A78A73Q34447158-6593C65F-42DE-4A1B-AA53-A821AD7A48A2Q34486542-B055363B-7200-416F-8C27-0B9AD2ACE5B2Q34699979-063225B8-3AF1-4998-BA74-B6C25178D318Q34739073-0776A174-9AB9-4715-8368-46D50876CAEAQ34979308-6F4C0D10-6CAB-4FD9-BC5A-07FB055ADAE5Q35013428-A7FEEA1A-4DC5-4073-87DE-E0BCEBF64145Q35239032-E6AA3373-1096-4029-A742-2865E7F1A97CQ35239043-C28FB7EA-5659-4A21-B874-9A28E4C0FF0EQ35268719-9BB38769-5B19-42CF-A7FA-400B77F5084FQ35291214-1E80060C-410F-40CA-947C-FE6CFA296618Q35550715-C69FF218-9BD9-42BD-ACF2-768745BB28CEQ35592875-E303E968-14C3-4DA6-912D-49324A8CA9C9
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Prognostic factors in ALS: A critical review
@ast
Prognostic factors in ALS: A critical review
@en
type
label
Prognostic factors in ALS: A critical review
@ast
Prognostic factors in ALS: A critical review
@en
prefLabel
Prognostic factors in ALS: A critical review
@ast
Prognostic factors in ALS: A critical review
@en
P2093
P2860
P50
P1476
Prognostic factors in ALS: A critical review
@en
P2093
Bryan G Traynor
Douglas Mitchell
Eurals Consortium
Robert Swingler
P2860
P304
P356
10.3109/17482960802566824
P577
2009-10-01T00:00:00Z